Sepsis survivors carry elevated psychiatric risk for five years
This nationwide Swedish cohort quantifies the long-term burden of new mood and anxiety morbidity after ICU-treated sepsis, reinforcing the pharmacist's role in post-sepsis psychotropic stewardship and mental health screening.
sepsispsychiatric morbiditydepressionanxietypsychotropic medicationshypnoticssedativesantidepressantspost-intensive care syndromeICU survivorshipregister cohortSwedenmatched cohortCritical Care / ICU
Background Information
Sepsis survivors face an increased risk of developing psychiatric disorders.
Understanding the link between sepsis and subsequent psychiatric morbidity can improve post-ICU care and support strategies. Sepsis patients showed a higher risk of psychiatric events compared to controls, especially within the first year, with attenuated but elevated risk up to five years. Highlighting the need for psychiatric monitoring in sepsis survivors; however, the study relies on registry data and may not capture all potential confounders. Sepsis significantly increases the risk of psychiatric disorders, particularly within the first year post-ICU.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.
Authors:Wetterberg H, Nilsson A, Linder A, Lengquist M, Frigyesi A, Sundén-Cullberg J, Inghammar M
Citation:Wetterberg H, Nilsson A, Linder A, et al. Sepsis and Subsequent Psychiatric Morbidity: A Nationwide Population-Based Matched Cohort Study, 2008-2019. Critical care medicine. 2026;54(7):1527-1533. doi:10.1097/CCM.0000000000007105
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Want the full analysis?
Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.